You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site.

Continue

Go back

Symptom assessment for your COPD patients

Go to Close Top

COPD Assessment Test (CAT)1

You can help your patients find out how their COPD is affecting their lives and how well they are managing their symptoms by simply using the COPD Assessment Test (CAT). – CAT is a questionnaire designed for use in routine clinical practice to measure the impact of COPD on patients’ lives and how this changes over time.1

  • The CAT is suitable for completion by all patients diagnosed with COPD.
  • Complete it with your patients during a consultation or suggest they complete it themselves at home.

To access the CAT, go to www.catestonline.org

GOLD Guidelines2

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) works with healthcare professionals and public health officials to raise awareness of COPD, and its guidelines aim to improve prevention and treatment.2

  • GOLD guidelines provide a useful reference tool to help you ensure your management of COPD patients is in line with the latest advice and evidence.

Click to download the 2021 GOLD pocket guide

To access the GOLD guidelines, go to https://goldcopd.org/2021-gold-reports/

References:

  1. Jones PW;European Society for Clinical Respiratory Physiology;2009;34;648-54 (v1.0)
  2. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (GOLD) 2021.

Anoro Ellipta was developed in collaboration with INNOVIVA Inc.

innovia logo

Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie . Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Trademarks are owned by or licensed to the GSK group of companies